This on-body injector for Neulasta (pegfilgrastim) enables cancer patients to receive chemotherapy treatment at home. The Neulasta Delivery Kit available from Amgen Assist means patients can get relief without having to return to the hospital after a chemo session, improving their conditions the day after treatment starts.
This on-body injector boosts white blood cells precisely 27 hours after chemotherapy treatment starts. This addresses a common side effect of chemo, neurtropenia. Even though this medicine has been available for a long time, it's proven difficult for cancer patients to receive their dosage because the chemo prevents them from returning to the hospital for an injection. The Neulasta Delivery Kit lets sufferers receive chemotherapy treatment at home, automatically activating the medicine the day after.
What Makes This Trend Stand Out
- On-body Medicine Injectors
- The use of on-body medicine injectors for chemotherapy at home is a disruptive innovation opportunity in the healthcare industry, improving patient conditions while reducing hospital visits.
- Remote Medical Care
- The application of remote medical care through on-body medicine injectors presents a disruptive innovation opportunity within the healthcare industry, allowing for treatment and care in any location.
- Personalized Healthcare
- The customization of healthcare through on-body medicine injectors presents a disruptive innovation opportunity in the healthcare industry, allowing patients to receive tailored treatment at home.
Sectors Adopting This
- Healthcare
- On-body medicine injectors present a disruptive innovation opportunity in the healthcare industry, providing increased mobility, convenience, and personalization for patients.
- Pharmaceuticals
- The use of on-body medicine injectors in pharmaceuticals presents a disruptive innovation opportunity to improve patient adherence to prescribed medication regimens and enhance treatment efficacy.
- Home Healthcare
- On-body medicine injectors are a disruptive innovation opportunity in the home healthcare industry, enabling patients to self-administer medication for conditions requiring frequent dosing.
